Sage Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Buy
1,895
+2
+0.1% +$466 0.19% 95
2026
Q1
$463K Hold
1,893
0.22% 93
2025
Q4
$392K Sell
1,893
-878
-32% -$174K 0.18% 102
2025
Q3
$514K Buy
2,771
+10
+0.4% +$1.71K 0.23% 86
2025
Q2
$422K Buy
2,761
+11
+0.4% +$1.69K 0.2% 94
2025
Q1
$456K Buy
2,750
+10
+0.4% +$1.56K 0.25% 87
2024
Q4
$396K Sell
2,740
-62
-2% -$9.61K 0.2% 101
2024
Q3
$454K Buy
2,802
+11
+0.4% +$1.75K 0.22% 93
2024
Q2
$408K Buy
2,791
+11
+0.4% +$1.64K 0.21% 97
2024
Q1
$440K Buy
2,780
+11
+0.4% +$1.75K 0.24% 92
2023
Q4
$434K Buy
+2,769
New +$425K 0.26% 88

Other funds holding JNJ

Sage Capital Management's JNJ Position: Q2 2026 in Review

Sage Capital Management increased its Johnson & Johnson (JNJ) stake by 0.11% in Q2 2026, buying an estimated $466 and bringing the position to 1,895 shares worth $482K. The position accounts for 0.19% of the portfolio, ranked #95.

Sage Capital Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $514K in Q3 2025. 1,809 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sage Capital Management held 1,895 shares of Johnson & Johnson worth $482K as of Q2 2026.
  • Sage Capital Management bought 2 Johnson & Johnson shares in Q2 2026, an estimated $466.
  • Johnson & Johnson made up 0.19% of Sage Capital Management's portfolio in Q2 2026, its #95 holding.
  • Sage Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Sage Capital Management's Johnson & Johnson position peaked at $514K in Q3 2025.
  • 1,809 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sage Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.